The Effect of Adenosine on Cranial Hemodynamic, Headache and Migraine Induction Properties.
Launched by DANISH HEADACHE CENTER · Sep 30, 2020
Trial Information
Current as of June 07, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Migraine patients without aura who fulfill criteria in the international classification of headaches. This does not apply to healthy volunteers.
- • 18-60 years.
- • 50-90 kg.
- • Women of childbearing potential must use adequate contraception
- Exclusion Criteria:
- • Headache less than 48 hours before the tests start
- • All primary headaches, except migraine without aura for migraine patients, according to international classification of headache
- • Daily consumption of drugs of any kind other than oral contraceptives
- • Pregnant or nursing women.
- • Cardiovascular disease of any kind, including cerebrovascular diseases.
About Danish Headache Center
The Danish Headache Center is a leading research institution dedicated to advancing the understanding and treatment of headache disorders. As a prominent clinical trial sponsor, the center focuses on innovative therapeutic approaches and comprehensive patient care, aiming to improve the quality of life for individuals suffering from various types of headaches, including migraines and tension-type headaches. With a multidisciplinary team of experts in neurology, psychology, and pain management, the Danish Headache Center is committed to conducting rigorous clinical trials that contribute to evidence-based practices and the development of novel interventions in headache research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glostrup, Nordre Ringvej 57, Denmark
Patients applied
Trial Officials
Messoud Ashina
Principal Investigator
Danish Headache Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials